The ₹1600 crore IPO opened for subscription on February 9.
The initial public offering (IPO) of products distributor firm Entero Healthcare Solutions opened on February 9 and will close on Tuesday. Though the ₹1600 crore IPO hoped to get by on day two with some positive response from retail investors, it was unsuccessful.
Read More: Vibhor Steel Tubes IPO to open today. Should you subscribe?
Competing with three other public offers, the IPO struggled to to get through on the first day, competing with the other three IPOs. Not much enthusiasm was expressed by the retail investors, and there was very little response from non-institutional investors.
Read More: Stocks to Watch: Coal India, ZEE, Eicher Motors, Hindalco, SAIL, Paytm, and Others
Entero Healthcare Solutions IPO subscription status on day 2
As per Mint, on the second day, the IPO’s subscription status was 19%: retail investors portion was subscribed 88%, Non-Institutional Investors (NII) portion was booked 9%, and Qualified Institutional Buyers (QIB) portion was yet to be booked. The employee portion, meanwhile, was subscribed 77%.
Read More: IPO Go-Ahead: Gopal Snacks, 2 Others Get Sebi’s Approval For Initial Public Offering
To subscribe or not?
As per brokerage firm Swastika Investmart Limited, Entero Healthcare Limited has ‘lost money in the last three fiscal years.’
“This is due to negative cash flows from financing, investing, and operating activities. Additionally, the company’s operations demand a large amount of working capital. As it has been at a loss, we cannot define its P/E valuation. However, due to its current financial condition and other risk factors, we will avoid this IPO,” Shivani Nyati, Head of Wealth, Swastika Investmart, told Mint.
(Disclaimer: Individual analyst’s view)
